Hassan Atef A, Mady Abdelrahman M, Abozied Hesham, Algammal Mohamed I, Hassan Amr A, Salman Mohamed, Metwally Mohamed E, Abouelmagd Moaz, Shouman Hossam A, Tagreda Ibrahim, Elsalhy Mohamed, Elnady Esam, Rehan Mohamed, Khater Saed
Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
Department of Urology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
J Robot Surg. 2025 Jul 11;19(1):373. doi: 10.1007/s11701-025-02511-1.
Ureteral reimplantation is a critical surgical procedure for restoring ureteral function, traditionally performed using open ureteral reimplantation (OUR). However, robotic-assisted ureteral reimplantation (RUR) has emerged as a minimally invasive alternative with potential perioperative advantages. To systematically compare the postoperative outcomes and efficacy of RUR and OUR in ureteral reimplantation in adults through a meta-analysis of existing studies. A comprehensive search of PubMed, Scopus, Web of Science, and the Cochrane Library identified studies comparing RUR and OUR in adults up to January 2025. Studies reporting at least one outcome of interest, such as complications, blood loss, hospital stay, or reintervention rates, were included. Pooled effect estimates were calculated using a random-effects model, and heterogeneity was assessed using the I statistic. Four retrospective studies encompassing 258 patients (RUR: 141, OUR: 117) were included. RUR was associated with significantly fewer complications (RR: 0.40; 95% CI: 0.17-0.91; p = 0.03), shorter hospital stays (MD: -4.97 days; 95% CI: -9.55 to -0.38; p = 0.03), and reduced transfusion requirements (RR: 0.09; 95% CI: 0.02-0.46; p = 0.004) compared to OUR. No significant differences were observed in reintervention rates or operating time. RUR demonstrates significant perioperative advantages over OUR, including reduced complications, shorter hospital stays, and lower blood loss, while maintaining comparable long-term efficacy. These findings support the adoption of RUR as a safe and effective alternative for ureteral reimplantation. Further high-quality, multicenter studies are needed to confirm these results and address remaining gaps.
输尿管再植术是恢复输尿管功能的关键外科手术,传统上采用开放式输尿管再植术(OUR)进行。然而,机器人辅助输尿管再植术(RUR)已成为一种具有潜在围手术期优势的微创替代方法。通过对现有研究的荟萃分析,系统比较RUR和OUR在成人输尿管再植术中的术后结果和疗效。全面检索了PubMed、Scopus、Web of Science和Cochrane图书馆,以确定截至2025年1月比较成人RUR和OUR的研究。纳入报告至少一项感兴趣结果(如并发症、失血、住院时间或再次干预率)的研究。使用随机效应模型计算合并效应估计值,并使用I统计量评估异质性。纳入了四项回顾性研究,共258例患者(RUR:141例,OUR:117例)。与OUR相比,RUR的并发症明显更少(RR:0.40;95%CI:0.17 - 0.91;p = 0.03),住院时间更短(MD:-4.97天;95%CI:-9.55至-0.38;p = 0.03),输血需求减少(RR:0.09;95%CI:0.02 - 0.46;p = 0.004)。在再次干预率或手术时间方面未观察到显著差异。RUR在围手术期显示出比OUR更显著的优势,包括并发症减少、住院时间缩短和失血减少,同时保持了相当的长期疗效。这些发现支持将RUR作为输尿管再植术的一种安全有效的替代方法。需要进一步的高质量、多中心研究来证实这些结果并填补剩余空白。